Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPER-CsA: Intracellular Cyclosporine A in Transplant
NCT00139009Phase 4Completed
- Sponsor
- University of Oslo School of Pharmacy
- Start
- Jun 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in kidney transplant rejection and heart transplant rejection, sponsored by University of Oslo School of Pharmacy. Primary endpoints: Rejection Episodes and Histology and Intralymphocyte Concentrations of Cyclosporine A. Started Jun 2005; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney transplant rejectionheart transplant rejection
Beyond the preview
Go deeper on NCT00139009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139009.